Detalhe da pesquisa
1.
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas.
Br J Cancer
; 121(2): 131-138, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217479
2.
Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Invest New Drugs
; 37(4): 797, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31020607
3.
Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.
Int J Cancer
; 142(11): 2355-2362, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313979
4.
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
N Engl J Med
; 373(5): 428-37, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222558
5.
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Invest New Drugs
; 36(1): 96-102, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119276
6.
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 36(1): 85-95, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726132
7.
Using circulating cell-free DNA to monitor personalized cancer therapy.
Crit Rev Clin Lab Sci
; 54(3): 205-218, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28393575
8.
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
Br J Cancer
; 117(1): 33-40, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588322
9.
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
Br J Cancer
; 116(12): 1505-1512, 2017 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463960
10.
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.
N Engl J Med
; 380(9): 888-889, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811920
11.
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553).
Invest New Drugs
; 35(5): 608-615, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204981
12.
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Lancet Oncol
; 17(12): 1683-1696, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836716
13.
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.
Oncology
; 91(6): 299-301, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27705967
14.
Long insert whole genome sequencing for copy number variant and translocation detection.
Nucleic Acids Res
; 42(2): e8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071583
15.
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
Proc Natl Acad Sci U S A
; 110(42): 16868-73, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24082123
16.
ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
Radiology
; 272(2): 568-76, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885982
17.
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
J Am Acad Dermatol
; 70(1): 60-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189279
18.
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs.
BMC Genomics
; 14: 302, 2013 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642077
19.
Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
Am J Pathol
; 181(1): 111-20, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22634180
20.
Determinants of patient screen failures in Phase 1 clinical trials.
Invest New Drugs
; 31(3): 774-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23135779